After the Bell
Before the Bell
Jim Cramer's Daily Booyah
Winners & Losers
Here's a technical look at how to trade five biotech stocks that are setting up to break out and trade much higher.
Besides Sanofi, Biogen is the next most likely to complete a sizable transaction in the next 12 months, according to Credit Suisse analysts.
Trade-Ideas LLC identified Intercept Pharmaceuticals (ICPT) as a "barbarian at the gate" (strong stocks crossing above resistance with today's range greater than 200%) candidate
Trade-Ideas LLC identified Intercept Pharmaceuticals (ICPT) as a weak on high relative volume candidate
©1996-2016 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.